Medtronic (NYSE:MDT) announced today that it completed its previously announced acquisition of Scientia Vascular for $550 million. In March, the medtech giant said it struck a deal to acquire Salt Lake City, Utah–based Scientia, which develops access products for treating complex neurovascular conditions. With the acquisition, Medtronic … [Read more...] about Medtronic completes acquisition of Scientia Vascular
Catheters
Penumbra wins FDA clearance for Thunderbolt computer-assisted vacuum thrombectomy for stroke
Penumbra (NYSE:PEN) announced today that it received FDA clearance for its Thunderbolt thrombectomy platform for stroke. Thunderbolt expands the Alameda, California-based company's computer-assisted vacuum thrombectomy (CAVT) portfolio. It aims to address acute ischemic stroke. Penumbra said Thunderbolt represents a first-of-its-kind … [Read more...] about Penumbra wins FDA clearance for Thunderbolt computer-assisted vacuum thrombectomy for stroke
Spectrum Vascular acquires catheter guidance tech developer Piccolo Medical
Spectrum Vascular announced today that it acquired catheter guidance product developer Piccolo Medical. White Plains, New York-based Spectrum Vascular said the acquisition deepens a partnership focused on bringing next-generation catheter guidance technology to the market. It said the move marks a significant step forward in its mission to … [Read more...] about Spectrum Vascular acquires catheter guidance tech developer Piccolo Medical
Airiver treats first patient in drug-coated balloon study for chronic rhinosinusitis
Airiver Medical today announced the successful treatment of the first patient in a pivotal clinical trial of its drug-coated balloon (DCB). The first patient received treatment for chronic rhinosinusitis (CRS) in its RESTORE-2 U.S. pivotal clinical trial. It evaluates the Brooklyn Park, Minnesota-based company's Airiver ESSpand sinus DCB. Dr. … [Read more...] about Airiver treats first patient in drug-coated balloon study for chronic rhinosinusitis
InspireMD has positive results for CGuard Prime in TCAR
InspireMD (Nasdaq:NSPR) today announced 30-day outcomes from a study of its CGuard Prime 80cm implant for use in TCAR procedures. Miami-based InspireMD launched CGuard Prime in the U.S. in July 2025 after receiving FDA premarket approval (PMA) the previous month. As of May, it reported 70,000 successful cases worldwide, including the majority of … [Read more...] about InspireMD has positive results for CGuard Prime in TCAR
Gore wins CE mark for Fortegra venous stent
W.L. Gore & Associates announced today that it received CE mark approval for its Viabahn Fortegra venous stent system. European approval comes about six months after the stent picked up FDA approval. The company labeled Viabahn Fortegra the first device for the treatment of deep venous disease in the inferior vena cava (IVC), iliac and … [Read more...] about Gore wins CE mark for Fortegra venous stent
Advanced NanoTherapies raises $31M for drug-coated balloon tech
Advanced NanoTherapies announced that it closed an oversubscribed Series B financing worth more than $31 million. An undisclosed strategic investor, along with S3 Ventures, co-led the round. The T45 Fund and new and existing investors also participated. Funding adds to $4 million raised in 2023. The funds support the company's therapies for … [Read more...] about Advanced NanoTherapies raises $31M for drug-coated balloon tech
Johnson & Johnson CMO explains advances behind ‘game-changer’ Shockwave C2 Aero catheter
With its $13 billion acquisition of Shockwave Medical in 2024, Johnson & Johnson added the market leader in intravascular lithotripsy (IVL) to its portfolio. Since then, the company has continued to build on that leadership position with new product rollouts. That includes the recent launch of Shockwave C2 Aero, the latest catheter system … [Read more...] about Johnson & Johnson CMO explains advances behind ‘game-changer’ Shockwave C2 Aero catheter
Adagio submits ventricular ablation system to FDA
Adagio Medical (Nasdaq:ADGM) announced today that it submitted its premarket approval (PMA) application to the FDA for its vCLAS system. The company submitted its vCLAS ventricular ablation system for the treatment of drug-refractory, recurrent, sustained monomorphic ventricular tachycardia (VT) in patients with ischemic or non-ischemic … [Read more...] about Adagio submits ventricular ablation system to FDA
Reflow Medical has positive data for coronary drug-eluting stent
Reflow Medical today announced the first six-month clinical results from a study of its Spur Elute sirolimus-eluting retrievable stent system. San Clemente, California-based Reflow designed its stent system to transfer a proprietary drug formulation to the diseased lesion without leaving a permanent metallic implant behind. The device’s … [Read more...] about Reflow Medical has positive data for coronary drug-eluting stent
